Our analysis shows frequent mutations and amplifications of SPOP in TCGA PRAD (prostate adenocarcinoma) and UCEC (uterine corpus endometrial carcinoma) cohorts. This evidence concerns the gene SPOP and prostate adenocarcinoma.